13.6 ± 3.1 mm, p = 0.278), although the latter differences did not reach statistical significance.
← all excerpts
High prevalence of treatable transthyretin cardiac amyloidosis in cardioembolic stroke: the first systematic cohort study.
1
—
—
13.6 ± 3.1 mm, p = 0.278), although the latter differences did not reach statistical significance.